GM22608
LCL from B-Lymphocyte
Description:
EHLERS-DANLOS SYNDROME: TYPE IV; ARTERIAL, ECCHYMOTIC TYPE
COLLAGEN, TYPE III, ALPHA-1; COL3A1
NEUROFIBROMATOSIS, TYPE I; NF1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Hereditary Cancers |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Family Member
|
1
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin confirmed by LINE assay |
|
Gene |
COL3A1 |
Chromosomal Location |
2q31 |
Allelic Variant 1 |
; EHLERS-DANLOS SYNDROME, TYPE IV |
Identified Mutation |
766delA |
Remarks |
Clinically affected; also has neurofibromatosis type I; see GM22609 Fibroblast; midface hypoplasia; dental crowding; micrognathia; high palate; cigarette paper scars; upper thoracic scoliosis; kyphosis; hyperextension in shoulders, right hip, and knees; neck mobility limited to the left and right; Beighton score 3/9; poor appetite and sleep; visual problems; 2 to 3 headaches per week related to TMJ; occasional swallowing problems; regular cough; occasional heavy chest pain; occasional gas; possible dissection in left gastric artery; splenic artery aneurysm measuring 1.8 cm; affected sister is GM22606; donor subject has a 1 bp deletion at nucleotide 766 of the COL3A1 gene [c.766delA] |
Gene Cards |
COL3A1 |
Gene Ontology |
GO:0004857 enzyme inhibitor activity |
|
GO:0005099 Ras GTPase activator activity |
|
GO:0005201 extracellular matrix structural constituent |
|
GO:0005581 collagen |
|
GO:0005586 collagen type III |
|
GO:0005737 cytoplasm |
|
GO:0006817 phosphate transport |
|
GO:0007265 Ras protein signal transduction |
|
GO:0008015 circulation |
|
GO:0008151 cell growth and/or maintenance |
|
GO:0008285 negative regulation of cell proliferation |
|
GO:0009887 organogenesis |
|
GO:0045786 negative regulation of cell cycle |
NCBI Gene |
Gene ID:1281 |
|
Gene ID:4763 |
NCBI GTR |
120180 COLLAGEN, TYPE III, ALPHA-1; COL3A1 |
|
130050 EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC |
|
162200 NEUROFIBROMATOSIS, TYPE I; NF1 |
OMIM |
120180 COLLAGEN, TYPE III, ALPHA-1; COL3A1 |
|
130050 EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC |
|
162200 NEUROFIBROMATOSIS, TYPE I; NF1 |
Omim Description |
EDS IV |
|
EDS4 |
|
EHLERS-DANLOS SYNDROME, ARTERIAL TYPE |
|
EHLERS-DANLOS SYNDROME, ECCHYMOTIC TYPE |
|
EHLERS-DANLOS SYNDROME, SACK-BARABAS TYPE |
|
EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT |
Split Ratio |
1:2 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|